While there is a CD99+/CD45− phenotype in Ewing sarcoma, CD45−, CD90+, CD56+, and CD57−/+ phenotypes are most frequently observed in rhabdomyosarcoma. This evidence concerns the gene CD99 and Ewing sarcoma.